Posted: February 23, 2019
In this first episode, Jeff Pike is joined by Collin Watson. Collin recently graduated with a dual MBA/MHA, and is in the middle of a leadership rotational program in the pharmaceutical industry. They cover an awesome variety of topics including Collin’s educational background & work experience, his passion for drug development, some of the work he has done already in strategy and marketing, current healthcare policy trends, and his key words of advice for future pharma professionals.
Posted: November 07, 2018
MSL Professional Jamie M. Dettler-Leonard, PhD, BCMAS from Johnson & Johnson discusses her experience with the BCMAS program on the Pharmacy Podcast Network.
Posted: June 28, 2018
According to the Edelman survey on trust, 77% of people surveyed refused to purchase a product or service because they did not trust the company behind it. Pharma companies are not exactly tops on the trust scale for reasons you can infer yourself—or listen to EP148 with Jennifer Miller on the Good Pharma Scorecard. As with most…Read More
Posted: June 21, 2018
An experienced executive with several years of experience in the pharmaceutical and biotechnology industry, Dr. Soliman has held key positions within medical affairs where he was instrumental in launching a variety of innovative platforms expanding the role of medical affairs across the industry.
Posted: March 07, 2019
Accreditation Council for Medical Affairs and Dynamic Global Events are excited to announce a partnership to bring the first ever CE accredited live events for pharmaceutical industry professionals. The first live event will be planned for July 2019.
Posted: Sept 06, 2018
The ACMA has appointed Dr. Charles Stacey, President and CEO of Accera Pharmaceuticals to its Board of Governors. Dr. Stacey is the President and CEO of Accera, a global clinical stage biotechnology company focused on the development of therapeutics for CNS disease. Prior to joining Accera, he was with Inventages, the Nestlé backed venture capital and private equity group, with $1.5Bn under management. There he led the CNS interest as well as the fund's interest in Asia. Prior to Inventages, Dr. Stacey ran a medical device company and worked for a number of early-stage healthcare companies.
Posted: Aug 30, 2018
The ACMA has appointed two power players to its Board of Governors Bob Oliver and S. Bob Chib.
Bob Oliver, Recent CEO of V ClinBio, former President and CEO of Otsuka Pharmaceuticals, who also serves as Executive Advisor for both Cellix Bio Sciences Inc and Hyalo Technologies, while serving on the Board of Directors for Neurotez Inc., joins the ACMA Board today.
S. Bob Chib, currently serves as the Head of Corporate Strategy, Innovation, and Business Development at Astellas Pharma. Mr. Chib has more than two decades' experience as a senior biopharma executive.
Posted: July 10, 2018
The partnership between the ACMA and Council for Continuing Pharmaceutical Education (CCPE) will enable more medical affairs and MSL professionals in Canada to become Board Certified in Medical Affairs via the Board Certified Medical Affairs Specialist Program (BCMAS). The CCPE and ACMA have collaborated to put together a first in class training program tailored for Canadian MSL professionals.
As Opioid Liability Rises, Accreditor Seeks Credential For Pharma's Educators As Specialty Drugs Gain Share, Trump Looks To Curb Prices. ACMA weighs in on the importance of certifying pharmaceutical professionals. ACMA Announces New Partnership with PhactMI a leading medical information provider in the pharmaceutical industry. ACMA now offers CME/CE for the First & Only Professional Board Certification Program for Medical Science Liaisons & Medical Affairs Professionals The ACMA announced today the appointment of Sotirios G. Stergiopoulos MD, MBEE, BCMAS as new President of the ACMA Board of Governors. Michael H. Davidson, MD joins the International Board of Medical Affairs Officers with the Accreditation Council for Medical Affairs (ACMA) The Board Certified Medical Affairs Specialist Program (BCMAS) comes to Rutgers University providing a new path forward for scientific and clinical professionals looking to work within the pharmaceutical industry
Posted: November 14, 2018
Posted: November 2, 2018
Posted: July 17, 2018
Imagine this scenario: a pharmacist makes a recommendation to a physician to either change, or add a medication to a patient’s regimen but the physician does not accept the recommendation since he or she is either unfamiliar with or does not have much experience with the drug and does not feel comfortable prescribing it. Medical affairs helps tear down these barriers so that both physicians and patients have access to scientifically accurate data and other information they need about a medication.....Read More
Four Reasons a Board Certification in Medical Affairs Will Benefit your company [January 25, 2018] Medical Affairs in 2018-What's coming? [January 17, 2018] Medical Affairs Outlook-A look back at 2017 [December 12, 2017] Medical Affairs Career? You're Certifiable! [August 28, 2017 Are you Ready to work.... Doctor? [June 19, 2017] 5 Smart Ways to Increase Medical Affairs Tenure Without Investing Much [March 28, 2017]